Skip to main content
. 2017 Oct 17;8(61):103919–103930. doi: 10.18632/oncotarget.21865

Figure 3. EED is a target of miR-590-3P.

Figure 3

(A) Protein levels of EED in HepG2 cells after transfection with miR-590-3P mimics, EED siRNA, miR-590-3P inhibitors or controls; (B) the analysis of the relative luciferase activities of EED-WT, EED-MUT in HepG2 cells after transfection with miR-590-3P mimics or miR-590-3P inhibitors; (C) protein levels of EED in MHCC97H cells after transfection with miR-590-3P mimics, EED siRNA, miR-590-3P inhibitors or controls; (D) the analysis of the relative luciferase activities of EED-WT, EED-MUT in MHCC97H cells after transfection with miR-590-3P mimics or miR-590-3P inhibitors; *p<0.05, **p<0.01, and ***p<0.001.